Related Experiment Video
Updated: Aug 10, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy
D B Clifford1, C Yiannoutsos, M Glicksman
1Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. cliffordd@neuro.wustl.edu
Abstract:
Introduction of highly active antiretroviral therapy (HAART) has been associated with many changes in the complications of human immunodeficiency virus (HIV) infection. A cohort of 25 HIV patients with progressive multifocal leukoencephalopathy (PML) treated with HAART experienced a median survival of >46 weeks. This is an improvement in prognosis compared with recent historic experience and correlated with HIV RNA viral load reductions. We conclude that current HIV therapy is important in improving the outlook of PML in the setting of HIV.
Related Concept Videos
Retrovirus Life Cycles
Cryptococcal Meningitis
Huntington Disease l: Introduction

